C – Reactive Protein Testing Market

Table of Contents

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           5.2.2 Restraints
           5.2.3 Opportunities
           5.2.4 Challenges

6 C-Reactive Protein Testing Market, By Assay Type
    6.1 Introduction
    6.2 Elisa 
    6.3 Clia
    6.4 Turbidimetric and Immunoturbidimetric Assay
    6.5 Others

7 C-Reactive Protein Testing Market, By Application
    7.1 Introduction
    7.2 Cardiovascular Diseases
    7.3 Inflammatory Bowel Disease
    7.4 Rheumatoid Arthritis
    7.5 Cancer
    7.6 Others 

8 C-Reactive Protein Testing Market, By End User
    8.1 Introduction
    8.2 Hospitals and Clinics
    8.3 Diagnostic Laboratories
    8.4 Others

9 C-Reactive Protein Testing Market, By Region
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 U.K
           9.3.2 Germany
           9.3.3 France
           9.3.4 Rest of Europe (RoE)
    9.4 Asia-Pacific
           9.4.1 China
           9.4.2 India
           9.4.3 RoAPAC
    9.5 Rest of the World (RoW)

10 Competitive Landscape
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends
             10.3.1 Agreements & Partnerships
             10.3.2 Acquisitions
             10.3.3 Expansions
             10.3.4 New Product Launches
             10.3.5 Other Developments

11 Company Profiles
     11.1 Introduction
     11.2 Abcam
     11.3 Biotechne (R&D Systems)
     11.4 F. Hoffmann-La Roche AG
     11.5 Randox Laboratories Ltd.
     11.6 Merck & Co., Inc.
     11.7 Thermo Fisher Scientific Inc.
     11.8 Lifespan Biosciences, Inc.
     11.9 Abaxis, Inc. 
     11.10 Quest Diagnostics
     11.11 Siemens Healthineers

12 Appendix

Note:
1 Above Segmentation May Change During the Course of Planned Research Work.
2 Financials, Recent Developments Might Not Be Captured in Case of Unlisted Companies.